• News
  • SAN DIEGO
  • General

Isis rings bell at Nasdaq

After making a presentation before one of Wall Street's key biotech investment conferences, Lynne Parshall, chief operating officer of Isis Pharmaceuticals Inc. (Nasdaq: ISIS), will ring the closing bell at the Nasdaq stock exchange Friday.

The bell-ringing follows Isis' presentation at the annual Leerink Swann Healthcare Conference. Despite some recent positive news for the company -- including a Food and Drug Administration green light for one of its drugs -- the stock price barely rose during the presentation, which was webcast live.

RELATED ARTICLE:

Isis Pharma shares rise on Kynamro approval

User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
44.62
  0.68  
+ 1.55%
1,703,078,000
77.8
37.38

Insider Trade Data

Date Insider Shares Type Value
10/02/2015 Parshall, B Lynne 12,436 Sell $506,747
10/02/2015 Parshall, B Lynne 12,436 Exchange $151,720
10/02/2015 Parshall, B Lynne 12,436 Sell $506,747
10/02/2015 Parshall, B Lynne 12,436 Exchange $151,720
07/06/2015 Parshall, B Lynne 12,436 Exchange $113,244

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chairman, Chief Executive Officer, Founder, President

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing